Five things for pharma marketers to know: Monday, July 17, 2017

Five things for pharma marketers to know: Monday, July 17, 2017

More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign

Pharma spending on CME rose in 2016

Pharma spending on CME rose in 2016

It's the third year of consecutive growth for spending on accredited CME, according to the Accreditation Council for Continuing Medical Education.

Five things for pharma marketers to know: Friday, July 14, 2017

Five things for pharma marketers to know: Friday, July 14, 2017

The FDA approves J&J psoriasis drug; PARP inhibitors are not cost-effective, ICER says; Verily releases mosquitoes to combat Zika

Five things for pharma marketers to know: Thursday, July 13, 2017

Five things for pharma marketers to know: Thursday, July 13, 2017

AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge

Novartis' CAR-T therapy gets nod from FDA committee

Novartis' CAR-T therapy gets nod from FDA committee

The drugmaker is one step closer to a potential approval of its experimental cancer treatment.

Five things for pharma marketers to know: Wednesday, July 12, 2017

Five things for pharma marketers to know: Wednesday, July 12, 2017

Former sales reps for Insys plead guilty to kickback allegations; digital health funding on the rise; PhRMA launches campaign about drug costs

Stubborn politicians get flooded by women's health facts via fax

Stubborn politicians get flooded by women's health facts via fax

How Huge and the New York Civil Liberties Union used lawmakers' own antiquated ideas to support the Reproductive Health Act.

Five things for pharma marketers to know: Tuesday, July 11, 2017

Five things for pharma marketers to know: Tuesday, July 11, 2017

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

The 2017 MM&M Awards: The Shortlist

The 2017 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

Otsuka's April Mitchell on leading versus managing

Otsuka's April Mitchell on leading versus managing

When you've figured out the difference, people will walk through fire for you, a mentor once told her.

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

The relative dearth of Pharma entries, and the fact that Lions Health is very much a separate affair to the rest of the week are two factors for the Lions to keep an eye on.

Five things for pharma marketers to know: Monday, July 10, 2017

Five things for pharma marketers to know: Monday, July 10, 2017

Gottlieb calls for new opioid training for docs; FDA committee to examine Novartis' CAR-T therapy; no Viagra ads expected during NFL season

Ancestry's first work from Droga5 makes a bold statement about America's diversity

Ancestry's first work from Droga5 makes a bold statement about America's diversity

The genomics brand brings together 29 descendants of the founding fathers for an atypical July Fourth campaign.

Five things for pharma marketers to know: Friday, July 7, 2017

Five things for pharma marketers to know: Friday, July 7, 2017

Drug ads on mobile are not providing enough risk info; rare-disease drugmakers are concerned about healthcare bill; volume of opioid prescriptions drops

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

The acquisition is meant to add creative expertise to the medical communications group.

Five things for pharma marketers to know: Thursday, July 6, 2017

Five things for pharma marketers to know: Thursday, July 6, 2017

The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial

Huntsworth buys health group TCEG for $28 million and signals U.S. ambition

Huntsworth buys health group TCEG for $28 million and signals U.S. ambition

TCG generated revenues of $29.6 million in 2016.

Five things for pharma marketers to know: Wednesday, July 5, 2017

Five things for pharma marketers to know: Wednesday, July 5, 2017

Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans

9 under the radar healthcare agencies to watch in 2017

9 under the radar healthcare agencies to watch in 2017

Here are nine agencies that are gaining traction in healthcare marketing.

MM&M's 2017 healthcare agency solar system

MM&M's 2017 healthcare agency solar system

Discover how M&A activity in 2016 and 2017 has reshaped North American healthcare agencies and the holding companies that own them.

The MM&M Agency Issue | The archives

The MM&M Agency Issue | The archives

Here you'll find the last four years of the MM&M Agency Issue.

Agencies embrace health, in bid to diversify beyond pharma

Agencies embrace health, in bid to diversify beyond pharma

Healthcare networks instigated a broad set of changes in a grand embrace of non-pharma business that diversified revenue streams and took specialist agencies out of their comfort zones.

The top 100 healthcare agencies, ranked by 2016 revenue

The top 100 healthcare agencies, ranked by 2016 revenue

Havas Health & You, WPP Health & Wellness, and Klick Health reported the highest revenue last year.

Questions for 5 of the healthcare agency world's top execs

Questions for 5 of the healthcare agency world's top execs

The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.

MM&M's 2017 Agency Issue

MM&M's 2017 Agency Issue

Read on for more about the top performing firms, the trends shaping the business, and the story behind each of the top 100 agencies.

Five things for pharma marketers to know: Friday, June 30, 2017

Five things for pharma marketers to know: Friday, June 30, 2017

The FDA plans to review orphan drug backlog; drugmaker supported charity helped patients pay for donor's drugs; low dose Xarelto gets Priority Review

Five things for pharma marketers to know: Thursday, June 29, 2017

Five things for pharma marketers to know: Thursday, June 29, 2017

Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Alison Lewis, the global chief marketing officer of Johnson & Johnson consumer division, has little appetite for new flavours and variants but instead wants to rethink innovation as a means to solve consumer problems.

Five things for pharma marketers to know: Wednesday, June 28, 2017

Five things for pharma marketers to know: Wednesday, June 28, 2017

Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck's CETP inhibitor anacetrapib and Novartis' monoclonal antibody ACZ885 hit their primary goals in late-stage cardiovascular outcomes trials, both unexpectedly positive results that are heating up this category.

Read the complete Patient Journey 2017 digital edition

Read the complete Patient Journey 2017 digital edition

Here you'll find everything from the Patient Journey 2017 supplement to our June issue.

Read the complete June 2017 digital edition

Read the complete June 2017 digital edition

Here you'll find everything from our June 2017 issue, including our Pharma Report, our Hall of Femme, and two roundtable discussions on media and oncology.

Pfizer celebrates the faces behind its vaccines with documentary

Pfizer celebrates the faces behind its vaccines with documentary

The video is part of Pfizer's ongoing corporate ad campaign Before it Became a Medicine.

Five things for pharma marketers to know: Tuesday, June 27, 2017

Five things for pharma marketers to know: Tuesday, June 27, 2017

Merck announces positive trial results for CETP inhibitor; Purdue Pharma defends withholding of OxyContin marketing material; Roche's experimental haemophilia drug significantly cuts bleed rate

LiquidHub acquires Eveo to form new health offering

LiquidHub acquires Eveo to form new health offering

The agency founded by Olivier Zitoun in 1999 has been snapped up as part of LiquidHub's push to offer multi-disciplinary capabilities.

Standing out in crowded cancer market

Standing out in crowded cancer market

Opdivo's marketing campaigns need to both market to and educate consumers about the new immunotherapy cancer treatment.

Five things for pharma marketers to know: Monday, June 26, 2017

Five things for pharma marketers to know: Monday, June 26, 2017

The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public

PulseCX promotes David Zaritsky to CEO

PulseCX promotes David Zaritsky to CEO

Zaritsky succeeds Jay Bolling, who becomes executive chairman

Five things for pharma marketers to know: Friday, June 23, 2017

Five things for pharma marketers to know: Friday, June 23, 2017

Novartis drug prevents heart attacks and strokes, per trial; Senate lawmakers unveil healthcare bill; Pfizer receives CRL for Epogen biosimilar

Five things for pharma marketers to know: Thursday, June 22, 2017

Five things for pharma marketers to know: Thursday, June 22, 2017

The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement

The FDA attempts to understand how disclosures affect drug ads

The FDA attempts to understand how disclosures affect drug ads

The FDA recently proposed studies designed to determine how disclosures in drug ads affect how viewers frame information.

Five things for pharma marketers to know: Wednesday, June 21, 2017

Five things for pharma marketers to know: Wednesday, June 21, 2017

Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections

How Zicam made the most of TV's cold season

How Zicam made the most of TV's cold season

How Zicam proved that there is a better, more data-driven approach to buying and measuring TV advertising..

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Area 23's Healthcare Agency of the Year win was four years in the making

Area 23's Healthcare Agency of the Year win was four years in the making

The FCB Health network won big this year with several campaigns, including work featuring a bra that detects breast cancer and an awareness campaign for human trafficking.

Five things for pharma marketers to know: Tuesday, June 20, 2017

Five things for pharma marketers to know: Tuesday, June 20, 2017

Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers are increasingly facing blame from regulators, lawmakers, and the public as the list of lawsuits and investigations at the state and local levels grows.

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Under siege from intense competition and the rise of value-based contracts, diabetes drugmakers look to outcomes data to stand out.

Five things for pharma marketers to know: Monday, June 19, 2017

Five things for pharma marketers to know: Monday, June 19, 2017

Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors

Day 2 at Lions Health: Watson's got its eye on you, Cannes

Day 2 at Lions Health: Watson's got its eye on you, Cannes

There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.

Lions Health: The 2017 health and wellness winners

Lions Health: The 2017 health and wellness winners

An Australian road safety campaign caught the eyes of the judges.

Lions Health: The 2017 pharma winners

Lions Health: The 2017 pharma winners

A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.

Lions Health jury declines to award a pharma Grand Prix

Lions Health jury declines to award a pharma Grand Prix

The jury said the year's best work in the category was a public-health campaign.

U.S. campaigns make up one-third of Lions Health pharma shortlist

U.S. campaigns make up one-third of Lions Health pharma shortlist

In the Lions Health pharma shortlist, released Saturday morning, five branded campaign made it through the judging process for the branded prescription categories.

Five things for pharma marketers to know: Friday, June 16, 2017

Five things for pharma marketers to know: Friday, June 16, 2017

Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO

Five things for pharma marketers to know: Thursday, June 15, 2017

Five things for pharma marketers to know: Thursday, June 15, 2017

Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research

AMA votes to require disclosure of drug prices in DTC ads

AMA votes to require disclosure of drug prices in DTC ads

The association also recommended that the Centers for Medicare and Medicaid Services negotiate drug prices.

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

The FDA-approved app will allow MS patients to share their medication injection history with HCPs.

Half of clinical-trial sites offer free transportation to patients

Half of clinical-trial sites offer free transportation to patients

Consent forms and reimbursement are the main deterrents of offering the service.

Five things for pharma marketers to know: Wednesday, June 14, 2017

Five things for pharma marketers to know: Wednesday, June 14, 2017

Sanofi to boost investment in biologics R&D; Sage's awareness campaign criticized; PatientsLikeMe poll finds 95% of patients want some costs of drugs covered

Five things for pharma marketers to know: Tuesday, June 13, 2017

Five things for pharma marketers to know: Tuesday, June 13, 2017

Alkermes lobbies lawmakers on its opioid addiction drug; rep salaries rise; SCOTUS rules in favor of Sandoz in biosimilar suit

Roundtable: When it comes to media, pharma compares the new with the old

Roundtable: When it comes to media, pharma compares the new with the old

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.

Five things for pharma marketers to know: Monday, June 12, 2017

Five things for pharma marketers to know: Monday, June 12, 2017

Teva gets FDA approval for Truvada generic; the FDA rejects Coherus' Neulasta biosimilar; only 17% of Americans find health industries to be innovative

Healthcare brands turn to emotion, to better tell their stories

Healthcare brands turn to emotion, to better tell their stories

It's never been easy for pharmaceutical companies or healthcare brands to authentically engage with patients or with doctors.

How Dana Maiman does Cannes

How Dana Maiman does Cannes

The CEO of FCB Health shares her gelato secrets and talks about why this year is truly the year of healthcare.

How Graham Mills does Cannes

How Graham Mills does Cannes

He buys macarons to make friends and finds that Cannes is an "extraordinary opportunity to rewire your brain."

How Ritesh Patel does Cannes

How Ritesh Patel does Cannes

Words of the wise: Vacant the Gutter Bar by 2 a.m., and make sure to bring flip flops and go walk on the beach.

Astellas reprimanded by U.K. drug regulator

Astellas reprimanded by U.K. drug regulator

The drugmaker has been handed a "public reprimand" by the U.K.'s Prescription Medicines Code of Practice Authority after the creative director of an unnamed agency used the company's patient support materials on its website.

Five things for pharma marketers to know: Friday, June 9, 2017

Five things for pharma marketers to know: Friday, June 9, 2017

The FDA asks Endo to take opioid off the market; Lilly partners with Swiss biotech; House committee advances PDUFA bill — without off-label provision

Live @ the MM&M Hall of Femme: Women talk about taking action to bridge the gender gap

Live @ the MM&M Hall of Femme: Women talk about taking action to bridge the gender gap

Executives discussed the challenges and opportunities they have faced as women.

Five things for pharma marketers to know: Thursday, June 8, 2017

Five things for pharma marketers to know: Thursday, June 8, 2017

Novartis CAR-T drug boasts competitive response rates; WPP reports slowing sales for healthcare business; AZ sells migraine drug

How should pharma market to millennials?

How should pharma market to millennials?

The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.

Five things for pharma marketers to know: Wednesday, June 7, 2017

Five things for pharma marketers to know: Wednesday, June 7, 2017

Pfizer receives breakthrough designation for experimental rare disease drug; Endocyte cuts 30 jobs; AbbVie RA drug meets Phase-III goals

PDUFA amendment would broaden off-label rules

PDUFA amendment would broaden off-label rules

The bill, introduced in March, is being considered as an amendment in the upcoming PDUFA reauthorization legislation.

23andMe partners with 'Despicable Me 3' for first movie partnership

23andMe partners with 'Despicable Me 3' for first movie partnership

The genetics testing company helps Gru find his lost-lost brother in six-week marketing push.

Voice assistants may ease EHR burden for docs, but challenges exist

Voice assistants may ease EHR burden for docs, but challenges exist

With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.

Five things for pharma marketers to know: Tuesday, June 6, 2017

Five things for pharma marketers to know: Tuesday, June 6, 2017

Pfizer increased drug prices by 20% in 2017; Perrigo CEO to retire; MannKind sponsors reality TV show to promote Afrezza

Physicians call for DTC ads to include retail prices

Physicians call for DTC ads to include retail prices

They are asking the American Medical Association to support the policy proposal.

Sunday at ASCO: What the latest trial data has to say about precision medicine

Sunday at ASCO: What the latest trial data has to say about precision medicine

Notably, data for AstraZeneca's Lynparza, Johnson & Johnson's Zytiga, and Loxo Oncology's larotrectinib highlights the move toward specialized medicine.

Five things for pharma marketers to know: Monday, June 5, 2017

Five things for pharma marketers to know: Monday, June 5, 2017

Medicare beneficiaries struggle to pay for COPD inhalers; Novartis partners with IBM Watson Health; Mylan hasn't lowered EpiPen prices

Saturday at ASCO: Trial results reveal promising data for combo I-O drugs but no home runs

Saturday at ASCO: Trial results reveal promising data for combo I-O drugs but no home runs

Putting aside the hype around combination immunotherapies, concerns remain about overall response rates for these drugs.

Why Novartis' Shah-Mehta chose a career in pharma sales

Why Novartis' Shah-Mehta chose a career in pharma sales

The executive director of oncology marketing is fascinated by the resilience of the human body.

Five things for pharma marketers to know: Friday, June 2, 2017

Five things for pharma marketers to know: Friday, June 2, 2017

Oncologists more likely to prescribe drugs when receiving travel, meal payments; Tesaro reportedly considering a sale; AbbVie has best pharma reputation

Roundtable: Social centricity in oncology

Roundtable: Social centricity in oncology

Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.

Five things for pharma marketers to know: Thursday, June 1, 2017

Five things for pharma marketers to know: Thursday, June 1, 2017

50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera

The immuno-oncology market prepares for the inevitable question: 'What's next?'

The immuno-oncology market prepares for the inevitable question: 'What's next?'

This includes concerns about the effectiveness — and cost-effectiveness — of drugs like Merck's Keytruda and Bristol-Myers Squibb's Opdivo, in combination or alone.

Five things for pharma marketers to know: Wednesday, May 31, 2017

Five things for pharma marketers to know: Wednesday, May 31, 2017

BMS partners on Opdivo combo; one-quarter of insurers have signed an outcomes-based contract with a drugmaker; rebates do not lead to savings for Medicare beneficiaries

Outcome Health raises $500 million in financing round

Outcome Health raises $500 million in financing round

The deal highlights ongoing interest in the influential point-of-care market.

Five things for pharma marketers to know: Tuesday, May 30, 2017

Five things for pharma marketers to know: Tuesday, May 30, 2017

Harvard Pilgrim signs two outcomes contracts with AstraZeneca; lobbyists fight over drug-pricing proposals; docs say no to adult ADHD screening test

Advocacy groups add a shade of resistance to Pride celebrations

Advocacy groups add a shade of resistance to Pride celebrations

The tone has changed dramatically since last year for LGBT rights groups, which are now as focused on opposing the Trump administration's policies as celebrating progress and community.

2017 Pharma Report: All the data in one place

2017 Pharma Report: All the data in one place

Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.

Pricing pressure is the new new normal for drugmakers

Pricing pressure is the new new normal for drugmakers

Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Following Tymlos approval, Radius uses Facebook to educate about osteoporosis

Following Tymlos approval, Radius uses Facebook to educate about osteoporosis

The company said adult women between the ages of 50 and 70 are most likely to share content on the social media platform.

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Twitter launches DM cards for brands

Twitter launches DM cards for brands

Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.

Five things for pharma marketers to know: Wednesday, May 24, 2017

Five things for pharma marketers to know: Wednesday, May 24, 2017

Keytruda receives first approval based on a genetic feature and not tumor's location; Alexion reps reportedly crossed ethical lines; profits up at insurers

The FDA cites risk info in letter over Contrave DTC ad

The FDA cites risk info in letter over Contrave DTC ad

The regulator also took issue with how Orexigen Therapeutics presented the risk information

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.